Lance, McCaul Measures Pass As Part Of House-renewed FDA Act – Ripon Advance
Lance, McCaul measures pass as part of House-renewed FDA Act – Ripon Advance
The U.S. House passed the FDA Reauthorization Act on Wednesday, which included provisions championed by U.S. Reps. Leonard Lance (R-NJ) and Michael McCaul (R-TX) to improve clinical trials and pediatric cancer research.
The legislation, which also included the reauthorization of the Food and Drug Administration’s critical user fee programs, now heads to the U.S. Senate for consideration.
Specifically, the bipartisan effort by Lance, who teamed up with Rep. Diana DeGette (D-CO), to improve clinical trials, was included in the legislation and unanimously passed as part of the overall act.
The measure would improve the way clinical …